# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
107, Journal, 0, 10, "J Diabetes", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasJournal> \"J Diabetes\"."
1, PublicationYear, 13, 17, "2013", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasPublicationYear> \"2013\"."
26, Title, 99, 286, "Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo - controlled 54 - week trial in patients with type 2 diabetes .", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasTitle> \"Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo - controlled 54 - week trial in patients with type 2 diabetes .\"."
2, Sitagliptin, 122, 133, "sitagliptin", "", 
9, Metformin, 151, 160, "metformin", "", 
13, Rosiglitazone, 165, 178, "rosiglitazone", "", 
17, Randomized, 204, 214, "randomized", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
104, Placebo, 215, 222, "placebo", "", 
18, Duration, 236, 245, "54 - week", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasCTduration> \"54 - week\"."
20, Type2Diabetes, 269, 284, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
27, Author, 287, 294, "Dobs AS", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Dobs AS\"."
28, Author, 303, 315, "Goldstein BJ", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Goldstein BJ\"."
29, Author, 318, 327, "Aschner P", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Aschner P\"."
30, Author, 330, 339, "Horton ES", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Horton ES\"."
31, Author, 342, 354, "Umpierrez GE", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Umpierrez GE\"."
32, Author, 357, 364, "Duran L", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasAuthor> \"Duran L\"."
33, Author, 367, 374, "Hill JS", "", 
34, Author, 377, 383, "Chen Y", "", 
35, Author, 386, 393, "Golm GT", "", 
36, Author, 396, 406, "Langdon RB", "", 
37, Author, 409, 429, "Williams - Herman DE", "", 
38, Author, 432, 442, "Kaufman KD", "", 
39, Author, 445, 456, "Amatruda JM", "", 
40, Author, 459, 470, "Ferreira JC", "", 
41, USA, 563, 566, "USA", "", "<http://ctro/data#Population_39639> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
21, Type2Diabetes, 665, 680, "type 2 diabetes", "", 
22, Type2Diabetes, 683, 686, "T2D", "", 
42, ObjectiveDescription, 756, 895, "The present study assessed the efficacy and safety of sitagliptin as add - on therapy to metformin and rosiglitazone in patients with T2D .", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasObjectiveDescription> \"The present study assessed the efficacy and safety of sitagliptin as add - on therapy to metformin and rosiglitazone in patients with T2D .\"."
4, Sitagliptin, 810, 821, "sitagliptin", "", 
63533, Precondition, 825, 893, "add - on therapy to metformin and rosiglitazone in patients with T2D", "", "<http://ctro/data#Population_39639> <http://ctro/data#hasPrecondition> \"add - on therapy to metformin and rosiglitazone in patients with T2D\"."
10, Metformin, 845, 854, "metformin", "", 
14, Rosiglitazone, 859, 872, "rosiglitazone", "", 
23, Type2Diabetes, 890, 893, "T2D", "", 
43, Randomized, 930, 940, "randomized", "", 
44, DoubleBlind, 941, 955, "double - blind", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
105, Placebo, 956, 963, "placebo", "", 
45, Parallel, 977, 993, "parallel - group", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
46, Duration, 994, 1003, "54 - week", "", 
144, Multicenter, 1023, 1031, "41 sites", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
47, NumberPatientsCT, 1086, 1089, "278", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasNumberPatientsCT> \"278\"."
48, HbA1c, 1104, 1109, "HbA1c", "", 
49, Percentage, 1131, 1132, "%", "", 
50, Percentage, 1145, 1146, "%", "", 
11, Metformin, 1188, 1197, "metformin", "", 
52, DoseValue, 1200, 1206, "≥ 1500", "", 
54, mg, 1207, 1209, "mg", "", 
56, Frequency, 1212, 1215, "day", "", 
15, Rosiglitazone, 1222, 1235, "rosiglitazone", "", 
53, DoseValue, 1238, 1241, "≥ 4", "", 
55, mg, 1242, 1244, "mg", "", 
57, Frequency, 1247, 1250, "day", "", 
58, Randomized, 1269, 1279, "randomized", "", 
59, AllocationRatio, 1282, 1287, "2 : 1", "", "<http://ctro/data#AllocationRatio_39627> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio>. <http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_39627>."
5, Sitagliptin, 1301, 1312, "sitagliptin", "", "<http://ctro/data#Medication_39689> <http://ctro/data#hasDrug> <http://ctro/data#Sitagliptin>."
60, DoseValue, 1313, 1316, "100", "", "<http://ctro/data#Medication_39689> <http://ctro/data#hasDoseValue> \"100\"."
61, mg, 1317, 1319, "mg", "", "<http://ctro/data#Medication_39689> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
62, Placebo, 1323, 1330, "placebo", "", "<http://ctro/data#Medication_39696> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
63, Frequency, 1331, 1341, "once daily", "", "<http://ctro/data#Intervention_39665> <http://ctro/data#hasFrequency> \"once daily\". <http://ctro/data#Intervention_39671> <http://ctro/data#hasFrequency> \"once daily\"."
162, TimePoint, 1385, 1393, "baseline", "", 
64, HbA1c, 1397, 1402, "HbA1c", "", 
65, TimePoint, 1406, 1413, "Week 18", "", 
165, Mean, 1426, 1430, "Mean", "", 
166, TimePoint, 1431, 1439, "baseline", "", 
66, HbA1c, 1440, 1445, "HbA1c", "", 
67, BaseLineValue, 1450, 1455, "8 . 8", "", 
68, Percentage, 1456, 1457, "%", "", 
170, Mean, 1464, 1468, "mean", "", "<http://ctro/data#Mean_39723> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_39721> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_39723>."
69, Placebo, 1469, 1476, "placebo", "", 
172, TimePoint, 1500, 1508, "baseline", "", 
70, HbA1c, 1512, 1517, "HbA1c", "", "<http://ctro/data#Endpoint_39721> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
6, Sitagliptin, 1523, 1534, "sitagliptin", "", 
106315, DiffGroupAbsValue, 1549, 1556, "- 0 . 7", "", "<http://ctro/data#DiffBetweenGroups_91987> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 7\"."
73, Percentage, 1557, 1558, "%", "", "<http://ctro/data#Endpoint_39721> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
106316, PvalueDiff, 1561, 1572, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_91987> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
77, TimePoint, 1578, 1585, "Week 18", "", "<http://ctro/data#Outcome_39726> <http://ctro/data#hasTimePoint> \"Week 18\". <http://ctro/data#Outcome_91933> <http://ctro/data#hasTimePoint> \"Week 18\"."
106318, DiffGroupAbsValue, 1590, 1597, "- 0 . 8", "", "<http://ctro/data#DiffBetweenGroups_91996> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 8\"."
74, Percentage, 1598, 1599, "%", "", 
106317, PvalueDiff, 1602, 1613, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_91996> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
78, TimePoint, 1619, 1626, "Week 54", "", "<http://ctro/data#Outcome_39753> <http://ctro/data#hasTimePoint> \"Week 54\". <http://ctro/data#Outcome_91960> <http://ctro/data#hasTimePoint> \"Week 54\"."
85, ObservedResult, 1629, 1683, "There were also significant ( P < 0 . 001 ) reductions", "", "<http://ctro/data#Outcome_39785> <http://ctro/data#hasObservedResult> \"There were also significant ( P < 0 . 001 ) reductions\". <http://ctro/data#Outcome_39812> <http://ctro/data#hasObservedResult> \"There were also significant ( P < 0 . 001 ) reductions\". <http://ctro/data#Outcome_39844> <http://ctro/data#hasObservedResult> \"There were also significant ( P < 0 . 001 ) reductions\". <http://ctro/data#Outcome_39871> <http://ctro/data#hasObservedResult> \"There were also significant ( P < 0 . 001 ) reductions\"."
80, PValueChangeValue, 1659, 1670, "P < 0 . 001", "", "<http://ctro/data#Outcome_39785> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 001\". <http://ctro/data#Outcome_39812> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 001\". <http://ctro/data#Outcome_39844> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 001\". <http://ctro/data#Outcome_39871> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 001\"."
106, PostprandialBloodGlucose, 1687, 1712, "2 - h post - meal glucose", "", "<http://ctro/data#Endpoint_39780> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialBloodGlucose>."
79, FastingPlasmaGlucose, 1717, 1739, "fasting plasma glucose", "", "<http://ctro/data#Endpoint_39839> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
81, Placebo, 1754, 1761, "placebo", "", 
187, TimePoint, 1765, 1780, "Weeks 18 and 54", "", "<http://ctro/data#Outcome_39812> <http://ctro/data#hasTimePoint> \"Weeks 18 and 54\". <http://ctro/data#Outcome_39871> <http://ctro/data#hasTimePoint> \"Weeks 18 and 54\"."
82, TimePoint, 1765, 1773, "Weeks 18", "", "<http://ctro/data#Outcome_39785> <http://ctro/data#hasTimePoint> \"Weeks 18\". <http://ctro/data#Outcome_39844> <http://ctro/data#hasTimePoint> \"Weeks 18\"."
7, Sitagliptin, 1819, 1830, "sitagliptin", "", 
84, Placebo, 1838, 1845, "placebo", "", 
86, HbA1c_target, 1869, 1884, "HbA1c < 7 . 0 %", "", "<http://ctro/data#Endpoint_39898> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
192, Percentage, 1883, 1884, "%", "", 
87, TimePoint, 1888, 1896, "Weeks 18", "", "<http://ctro/data#Outcome_39903> <http://ctro/data#hasTimePoint> \"Weeks 18\". <http://ctro/data#Outcome_39930> <http://ctro/data#hasTimePoint> \"Weeks 18\"."
89, PercentageAffected, 1899, 1901, "22", "", "<http://ctro/data#Outcome_39903> <http://ctro/data#hasPercentageAffected> \"22\"."
90, PercentageAffected, 1907, 1908, "9", "", "<http://ctro/data#Outcome_39930> <http://ctro/data#hasPercentageAffected> \"9\"."
203, PvalueDiff, 1913, 1924, "P = 0 . 003", "", "<http://ctro/data#DiffBetweenGroups_40011> <http://ctro/data#hasPvalueDiff> \"P = 0 . 003\"."
88, TimePoint, 1931, 1933, "54", "", "<http://ctro/data#Outcome_39957> <http://ctro/data#hasTimePoint> \"54\". <http://ctro/data#Outcome_39984> <http://ctro/data#hasTimePoint> \"54\"."
91, PercentageAffected, 1936, 1938, "26", "", "<http://ctro/data#Outcome_39957> <http://ctro/data#hasPercentageAffected> \"26\"."
92, PercentageAffected, 1944, 1946, "14", "", "<http://ctro/data#Outcome_39984> <http://ctro/data#hasPercentageAffected> \"14\"."
204, PvalueDiff, 1951, 1962, "P = 0 . 015", "", "<http://ctro/data#DiffBetweenGroups_40020> <http://ctro/data#hasPvalueDiff> \"P = 0 . 015\"."
95, BodyWeight, 1978, 1989, "body weight", "", 
96, BodyWeight, 2007, 2021, "adverse events", "", 
97, Hypoglycemia, 2032, 2044, "hypoglycemia", "", 
98, GastrointestinalProblem, 2051, 2082, "gastrointestinal adverse events", "", 
100, ObservedResult, 2083, 2133, "were similar in the sitagliptin and placebo groups", "", 
8, Sitagliptin, 2103, 2114, "sitagliptin", "", 
99, Placebo, 2119, 2126, "placebo", "", 
19, Duration, 2145, 2154, "54 - week", "", 
102, ConclusionComment, 2177, 2375, "In patients with T2D , the addition of sitagliptin for 54 weeks to ongoing therapy with metformin and rosiglitazone improved glycemic control and was generally well tolerated compared with placebo .", "", "<http://ctro/data#ClinicalTrial_39623> <http://ctro/data#hasConclusionComment> \"In patients with T2D , the addition of sitagliptin for 54 weeks to ongoing therapy with metformin and rosiglitazone improved glycemic control and was generally well tolerated compared with placebo .\"."
24, Type2Diabetes, 2194, 2197, "T2D", "", 
3, Sitagliptin, 2216, 2227, "sitagliptin", "", 
25, Duration, 2232, 2240, "54 weeks", "", 
12, Metformin, 2265, 2274, "metformin", "", 
16, Rosiglitazone, 2279, 2292, "rosiglitazone", "", 
101, Placebo, 2366, 2373, "placebo", "", 
103, PMID, 2545, 2553, "22742523", "", "<http://ctro/data#Publication_39616> <http://ctro/data#hasPMID> \"22742523\"."
